Well it was tested at Harborside and dude was told they usually see around 42-44% in top shelf shit
Harborside launches lab testing program
Concentrates found to contain more CBD than do flowers
By Shiloh Brotherman
In mid-December 2008, Harborside Health Center became the first dispensary in California to offer laboratory testing of its medicine. All flowers and concentrates distributed by the Oakland collective are now laboratory tested for safety and potency. It uses plate culture analysis to detect pathogenic molds invisible to the human eye, which may pose a health hazard to patients with compromised immune systems. Potency tests use gas chromatography/ mass spectrometry/flame ionization detection to measure the percentages of three major cannabinoids: THC, CBD, and CBN.
Harborside CEO Steve DeAngelo greeted the program with enthusiasm “For first time in the history of human cannabis consumption, patients have a scientific assessment of the safety and potency of their medicine prior to ingesting it.”
The program is the result of a long and painstaking development process, undertaken in partnership with the Analytical Laboratory Project. The seeds of the program were planted at the 2007 NORML conference, when ALP founders David Lampach and Addison DeMoura met lifelong activist DeAngelo.
“Everybody we talked to said it had been tried before, but that it was impossible” said Lampach, “We never believed that; and when we met Steve, he agreed and encouraged us to develop the testing program. So we took the plunge and started purchasing equipment.”
Over the course of the next 18 months, ALP developed analytical methods in partnership with a senior bio-chemist from one of the Bay Area’s most prestigious research institutions. Additional scientific oversight is provided by London’s Institute of Psychiatry and the University of the City of London, in a partnership with the internationally renowned Beckley Foundation.
The ultimate goal of the partnership is the development of a comprehensive database to compile patient evaluations of tested medicine samples. This database could one day identify the most therapeutically active components in the cannabis plant, and guide future development of cannabinoid medicines. Lady Amanda Neidpath, Director of the Beckley Foundation, commented, “It could very well be a scientific gold mine.” After a short beta phase at Harborside, ALP will extend the testing program to dispensaries, collectives, and growers state-wide.
Results so far show that most of the medicine presented to Harborside is free of pathogenic molds; but some samples have traces of the aspergillus mold — possibly fatal to patients with very seriously compromised immune systems. Harborside returns to the grower all items found to contain any aspergillus and any that exceed American Herbal Products Assn. standards for mold content. Harborside THC content has ranged from 5.18 to 87.60 percent (including care packages and concentrates), with most flower varieties falling between 15 and 25 percent, and most concentrates between 20 and 80 percent.
Levels of CBD, a cannabinoid of intense interest to researchers, vary markedly between flowers and concentrates. CBD levels in flowers generally have been less than 1 percent, while concentrates — often made from leaf material — have up to three times more. Because researchers and some patients believe CBD has great therapeutic potential, this may be the most important finding of the program so far.
Ok folks so I've never been able to make a thread for hash cuz I never have any really!!! Well I was gifted some Blue Dream Full Melt made in a Bubblator and was tested at Harborside with a 68% THC content and they couldn't believe it!